<?xml version="1.0" encoding="UTF-8"?>
<p id="Par20">Our observations are in line with those in a phase 2 study of pixantrone monotherapy in patients with relapsed, aggressive NHL, in which several patients had very long CRs that lasted more than 1 year [
 <xref ref-type="bibr" rid="CR17">17</xref>]. In this study, two female patients with stage II DLBCL and stage IV mantle cell lymphoma experienced CRs lasting 17+ and 15.2 months, respectively. This study also included one patient (male; aged 66 years) with stage IV transformed follicular lymphoma who experienced a PR lasting 24+ months.
</p>
